Abstract
Dyslipidemia is a common, major modifiable risk factor for cardiovascular disease. Screening for lipid disorders is simple, and available treatments decrease disease risk. However, secondary causes of dyslipidemia are probably underappreciated, and severe lipid elevations should be referred to a lipid specialist. Patients usually respond to lifestyle modifications and drug therapy guided by a stepwise approach supported by the results of clinical trials, but several misconceptions may interfere with treatment strategies.
| Original language | English |
|---|---|
| Pages (from-to) | 107-112 |
| Number of pages | 6 |
| Journal | Missouri Medicine |
| Volume | 108 |
| Issue number | 2 |
| State | Published - Mar 2011 |